Wells Fargo & Company MN Boosts Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Wells Fargo & Company MN lifted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 25.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,543 shares of the medical instruments supplier's stock after purchasing an additional 2,784 shares during the quarter. Wells Fargo & Company MN owned 0.06% of ICU Medical worth $2,101,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Integrated Quantitative Investments LLC bought a new position in ICU Medical in the 4th quarter valued at $1,397,000. Cinctive Capital Management LP boosted its position in shares of ICU Medical by 91.4% during the 4th quarter. Cinctive Capital Management LP now owns 50,149 shares of the medical instruments supplier's stock valued at $7,782,000 after acquiring an additional 23,954 shares during the last quarter. Huntington National Bank grew its holdings in shares of ICU Medical by 6.2% during the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after purchasing an additional 82 shares in the last quarter. Franklin Resources Inc. increased its position in shares of ICU Medical by 65.1% in the fourth quarter. Franklin Resources Inc. now owns 19,333 shares of the medical instruments supplier's stock worth $3,000,000 after purchasing an additional 7,625 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after purchasing an additional 136 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Trading Up 0.2 %

ICUI traded up $0.30 during trading on Thursday, hitting $136.89. 29,993 shares of the stock traded hands, compared to its average volume of 273,558. The firm has a market capitalization of $3.37 billion, a P/E ratio of -29.95 and a beta of 0.86. ICU Medical, Inc. has a 12-month low of $96.97 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a 50-day moving average of $142.32 and a 200 day moving average of $157.35.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ICUI. KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. StockNews.com cut ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. Finally, Raymond James set a $97.00 target price on ICU Medical in a research note on Wednesday, March 12th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $162.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.